Ibrance 125 MG capsule 21S
Ended Awarded Last action
- Contract number
- SPE2DR26FY8JV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,555
Award facts
- Contract value 100% obligated
- $8,555.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ibrance 125 mg capsules (21-count packages) valued at $8,555.21 with a firm fixed price structure. The contract is classified as a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the Department of Defense's medical supply chain, providing brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. Ibrance, a prescription oncology medication, falls within the company's extensive portfolio of specialized pharmaceuticals delivered through the DLA Troop Support Medical contract vehicle. The delivery order demonstrates the company's ongoing capability to fulfill federal medical procurement requirements through competitive procurement processes and reflects the operational flexibility of the IDC structure in supporting Defense Health Agency and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FY8JV?
SPE2DR26FY8JV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FY8JV worth?
The government has obligated $8,555 on SPE2DR26FY8JV.
Is contract SPE2DR26FY8JV an order under another contract?
Yes. SPE2DR26FY8JV is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8JV competed?
The extent of competition for SPE2DR26FY8JV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award